AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Dainippon Sumitomo Pharma summary of consolidated financial results for the first quarter of the year ended 31 Mar 2010 (unaudited): development pipeline (as of 31 Jul 2009): major products under development in Japan by DSP.

Chemical Business Newsbase

| July 31, 2009 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Dainippon Sumitomo Pharma has reported on major products under development in Japan (as of 31 Jul 2009). NDA filed (miriplatin hydrate, metformin hydrochloride, and meropenem hydrate), Phase III …

Related articles from newspapers, magazines, journals, and more
Dainippon Sumitomo Pharma summary of consolidated financial results for 3Q of...
News wire article from: Chemical Business Newsbase February 3, 2009 700+ words
Dainippon Sumitomo Pharma summary of consolidated financial results for 3Q of...
News wire article from: Chemical Business Newsbase February 3, 2009 700+ words
Dainippon Sumitomo Pharma summary of consolidated financial results for 3Q of...
News wire article from: Chemical Business Newsbase February 3, 2009 700+ words
Dainippon Sumitomo Pharma summary of consolidated financial results for the...
News wire article from: Chemical Business Newsbase July 31, 2009 700+ words
Dainippon Sumitomo Pharma summary of consolidated financial results for the...
News wire article from: Chemical Business Newsbase July 31, 2009 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily